| NASDAQ (usa) |
 |
6715.56 | -12.11 | -0.18% |
| FTSE 100 (london) |
|
7487.96 | -5.12 | -0.07% |
| DAX (german) |
 |
13465.51 | 235.94 | 1.78% |
| NIKKEI 225 (japan) |
|
22420.08 | 408.47 | 1.86% |
| Hang - Seng (hong kong) |
|
28594.06 | 348.52 | 1.23% |
| NIFTY - 50 (india) | ||||
| Straits Times (singapore) |
|
3391.61 | 17.53 | 0.52% |
| KOSPI (korea) |
|
2556.47 | 33.04 | 1.31% |
| All Ordinaries (australia) |
|
6005.30 | 28.90 | 0.48% |
| BOVESPA (brazil) |
|
74092.76 | -215.73 | -0.29% |
Swedish Orphan Biovitrum AB (publ) (ST: SOBI)
SOBI Technical Analysis
1.5
| As on 17th Jun 2025 SOBI SHARE Price closed @ 280.60 and we RECOMMEND Sell for LONG-TERM with Stoploss of 287.48 & Buy for SHORT-TERM with Stoploss of 272.95 we also expect STOCK to react on Following IMPORTANT LEVELS. |
SOBISHARE Price
| Open | 286.00 | Change | Price | % |
| High | 286.00 | 1 Day | -8.00 | -2.77 |
| Low | 279.40 | 1 Week | -26.60 | -8.66 |
| Close | 280.60 | 1 Month | -19.20 | -6.40 |
| Volume | 284438 | 1 Year | 13.40 | 5.01 |
| 52 Week High 346.40 | 52 Week Low 246.60 | ||||
ST Sweden Most Active Stocks
| HDW-B | 0.00 | % |
| FING-B | 0.01 | 0.00% |
| LIPI | 0.22 | -4.35% |
| WYLD | 0.03 | 0.00% |
| QLINEA | 0.05 | 0.00% |
| S2M | 0.01 | 0.00% |
| QUIA | 0.00 | % |
| LUNE | 21.97 | 6.65% |
| POLY | 0.04 | 0.00% |
| ENERS | 0.00 | % |
ST Sweden Top Gainers Stocks
ST Sweden Top Losers Stocks
| SOBI Daily Charts |
SOBI Intraday Charts |
Whats New @ Bazaartrend |
SOBI Free Analysis |
|
|
SOBI Important Levels Intraday
| RESISTANCE | 293.32 |
| RESISTANCE | 289.24 |
| RESISTANCE | 286.72 |
| RESISTANCE | 284.20 |
| SUPPORT | 277.00 |
| SUPPORT | 274.48 |
| SUPPORT | 271.96 |
| SUPPORT | 267.88 |
SOBI Forecast June 2025
| 4th UP Forecast | 393.91 |
| 3rd UP Forecast | 357.57 |
| 2nd UP Forecast | 335.11 |
| 1st UP Forecast | 312.65 |
| 1st DOWN Forecast | 248.55 |
| 2nd DOWN Forecast | 226.09 |
| 3rd DOWN Forecast | 203.63 |
| 4th DOWN Forecast | 167.29 |
SOBI Weekly Forecast
| 4th UP Forecast | 313.74 |
| 3rd UP Forecast | 303.11 |
| 2nd UP Forecast | 296.54 |
| 1st UP Forecast | 289.97 |
| 1st DOWN Forecast | 271.23 |
| 2nd DOWN Forecast | 264.66 |
| 3rd DOWN Forecast | 258.09 |
| 4th DOWN Forecast | 247.46 |
SOBI Forecast2025
| 4th UP Forecast | 497.58 |
| 3rd UP Forecast | 427.99 |
| 2nd UP Forecast | 384.98 |
| 1st UP Forecast | 341.97 |
| 1st DOWN Forecast | 219.23 |
| 2nd DOWN Forecast | 176.22 |
| 3rd DOWN Forecast | 133.21 |
| 4th DOWN Forecast | 63.62 |
Swedish Orphan Biovitrum AB (publ) ( ST Sweden Symbol : SOBI )
Sector : Healthcare And Other Stocks in Same Sector
Sector : Healthcare And Other Stocks in Same Sector
SOBI Business Profile
Swedish Orphan Biovitrum AB (publ), an integrated biotechnology company, researches, develops, manufactures, and sells pharmaceuticals in the therapeutic areas of haematology, immunology, and genetic and metabolic diseases in Europe, North America, and internationally. It offers Alprolix for haemophilia B; Doptelet treatment of thrombocytopenia; Elocta for haemophilia A; Gamifant for hemophagocytic lymphohistiocytosis(HLH); Kineret for cryopyrin associated periodic syndrome, rheumatoid arthritis, and still's disease; Orfadin to treat hereditary tyrosinaemia type-1; and Synagis for serious lower respiratory tract infection. The company It also provides other products, such as Akynzeo, Aloxi, Ammonul, Betapred, Caphosol, Fibclot, IVheBex, and Willfact. In addition, it develops drug substance for ReFacto AF/Xyntha for Pfizer; BIVV001 for haemophilia A; and Nirsevimab for respiratory syncytial virus. The company has a strategic collaboration with Apellis Pharmaceuticals Inc. to develop pegcetacoplan for the treatment of multiple rare diseases, including paroxysmal nocturnal hemoglobinuria. Swedish Orphan Biovitrum AB (publ) is headquartered in Solna, Sweden. Address: Tomtebodavägen 23A, Solna, Sweden, 112 76
© 2005-2023 BazaarTrend.com All rights reserved.
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service
Data and information is provided for informational purposes only, and is not intended for trading purposes.
Neither BazaarTrend.com website nor any of its promoters shall be liable for any errors
or delays in the content, or for any actions taken in reliance thereon. Your use of this website constitutes
acceptance of our Terms Of Service